Posts with tag: fitness
Insmed Inc. (INSM) reported a Q4 loss of $235.5 million ($1.32/share) vs. the Zacks estimate of a $1.15 loss. The biopharmaceutical company posted revenue of $104.4 million, topping estimates of $104.3 million.
Published on: February 20, 2025, 01:09 PM UTC
Waabi, founded by Raquel Urtasun in 2021, has raised $280 million in funding to advance its AI-powered self-driving technology. Backed by investors like Nvidia and Uber, Waabi aims to revolutionize the transportation industry.
Published on: February 20, 2025, 12:04 PM UTC
US stocks closed higher on Wednesday as investors assessed President Trump's latest 25% tariff announcement and analyzed the Federal Reserve minutes for insights into future policy. The benchmark S&P 500 (^GSPC) gained about 0.2% to touch a new record high of 6,144.15, after hitting a record on Tuesday too. The Nasdaq Composite (^IXIC) and the Dow Jones Industrial Average (^DJI) both rose about 0.1%.
Published on: February 20, 2025, 11:02 AM UTC
Trump's economic advisors aim to lower borrowing costs by targeting the 10-year Treasury yield, influenced by market forces rather than the Fed's monetary policy. They believe controlling inflation and promoting growth will reduce the yield and free up capital for investments.
Published on: February 19, 2025, 03:03 PM UTC
Intel stock soared 16% on reports that Broadcom and TSMC may explore deals to split the chipmaker into two companies.
Published on: February 19, 2025, 01:03 PM UTC
BHP raises $3 billion through senior unsecured bonds in the United States
Published on: February 18, 2025, 11:03 PM UTC
International Flavors & Fragrances Inc. (IFF) reported a loss of $46 million in its fourth quarter, but earnings, adjusted for non-recurring costs, were 97 cents per share, beating Wall Street expectations. For the year, the company reported a profit of $243 million, or 95 cents per share.
Published on: February 18, 2025, 10:10 PM UTC
Vulcan Materials Co. (VMC) reported fourth-quarter earnings of $293.8 million, exceeding Wall Street expectations. The company posted revenue of $1.85 billion, also topping Street forecasts.
Published on: February 18, 2025, 01:06 PM UTC
NeoGenomics (NEO) missed Q4 sales estimates but still grew 10.6% YoY. Non-GAAP EPS beat estimates by $0.01. Revenue guidance for 2025 is slightly above analyst estimates, implying 12% growth. Get the full research report for valuation and investment insights.
Published on: February 18, 2025, 01:05 PM UTC
Fed's Harker anticipates further policy rate declines, citing resilient economy and progress on inflation.
Published on: February 17, 2025, 03:00 PM UTC